drugset / Trial / NCT02289261

A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain

NCT02289261 ↗

Phase 4 Completed 40 enrolled Cukurova University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.

Timeline

Start
2014-11
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.1 ug/kg —
Comparator Morphine Other / unclassified 0.02 mg/kg —

Indications